Kolberg M - Search Results

1

Transcriptomic subtyping of malignant peripheral nerve sheath tumours highlights immune signatures, genomic profiles, patient survival and therapeutic targets.

Høland M, Berg KCG, Eilertsen IA, Bjerkehagen B, Kolberg M, Boye K, Lingjærde OC, Guren TK, Mandahl N, van den Berg E, Palmerini E, Smeland S, Picci P, Mertens F, Sveen A, Lothe RA. Høland M, et al. Among authors: kolberg m. EBioMedicine. 2023 Nov;97:104829. doi: 10.1016/j.ebiom.2023.104829. Epub 2023 Oct 12. EBioMedicine. 2023. PMID: 37837931 Free PMC article.

2

Inferior survival for patients with malignant peripheral nerve sheath tumors defined by aberrant TP53.

Høland M, Kolberg M, Danielsen SA, Bjerkehagen B, Eilertsen IA, Hektoen M, Mandahl N, van den Berg E, Smeland S, Mertens F, Sundby Hall K, Picci P, Sveen A, Lothe RA. Høland M, et al. Among authors: kolberg m. Mod Pathol. 2018 Nov;31(11):1694-1707. doi: 10.1038/s41379-018-0074-y. Epub 2018 Jun 26. Mod Pathol. 2018. PMID: 29946184 Free article.

3

Identification of p53 as a strong predictor of survival for patients with malignant peripheral nerve sheath tumors.

Brekke HR, Kolberg M, Skotheim RI, Hall KS, Bjerkehagen B, Risberg B, Domanski HA, Mandahl N, Liestøl K, Smeland S, Danielsen HE, Mertens F, Lothe RA. Brekke HR, et al. Among authors: kolberg m. Neuro Oncol. 2009 Oct;11(5):514-28. doi: 10.1215/15228517-2008-127. Epub 2009 Jan 30. Neuro Oncol. 2009. PMID: 19182148 Free PMC article.

4

Genomic changes in chromosomes 10, 16, and X in malignant peripheral nerve sheath tumors identify a high-risk patient group.

Brekke HR, Ribeiro FR, Kolberg M, Agesen TH, Lind GE, Eknaes M, Hall KS, Bjerkehagen B, van den Berg E, Teixeira MR, Mandahl N, Smeland S, Mertens F, Skotheim RI, Lothe RA. Brekke HR, et al. Among authors: kolberg m. J Clin Oncol. 2010 Mar 20;28(9):1573-82. doi: 10.1200/JCO.2009.24.8989. Epub 2010 Feb 16. J Clin Oncol. 2010. PMID: 20159821

5

Survival meta-analyses for >1800 malignant peripheral nerve sheath tumor patients with and without neurofibromatosis type 1.

Kolberg M, Høland M, Agesen TH, Brekke HR, Liestøl K, Hall KS, Mertens F, Picci P, Smeland S, Lothe RA. Kolberg M, et al. Neuro Oncol. 2013 Feb;15(2):135-47. doi: 10.1093/neuonc/nos287. Epub 2012 Nov 15. Neuro Oncol. 2013. PMID: 23161774 Free PMC article. Review.

6

Methylated RASSF1A in malignant peripheral nerve sheath tumors identifies neurofibromatosis type 1 patients with inferior prognosis.

Danielsen SA, Lind GE, Kolberg M, Høland M, Bjerkehagen B, Sundby Hall K, van den Berg E, Mertens F, Smeland S, Picci P, Lothe RA. Danielsen SA, et al. Among authors: kolberg m. Neuro Oncol. 2015 Jan;17(1):63-9. doi: 10.1093/neuonc/nou140. Epub 2014 Jul 19. Neuro Oncol. 2015. PMID: 25038505 Free PMC article.

7

Protein expression of BIRC5, TK1, and TOP2A in malignant peripheral nerve sheath tumours--A prognostic test after surgical resection.

Kolberg M, Høland M, Lind GE, Ågesen TH, Skotheim RI, Hall KS, Mandahl N, Smeland S, Mertens F, Davidson B, Lothe RA. Kolberg M, et al. Mol Oncol. 2015 Jun;9(6):1129-39. doi: 10.1016/j.molonc.2015.02.005. Epub 2015 Feb 18. Mol Oncol. 2015. PMID: 25769404 Free PMC article. Clinical Trial.

8

Drug sensitivity and resistance testing identifies PLK1 inhibitors and gemcitabine as potent drugs for malignant peripheral nerve sheath tumors.

Kolberg M, Bruun J, Murumägi A, Mpindi JP, Bergsland CH, Høland M, Eilertsen IA, Danielsen SA, Kallioniemi O, Lothe RA. Kolberg M, et al. Mol Oncol. 2017 Sep;11(9):1156-1171. doi: 10.1002/1878-0261.12086. Epub 2017 Jul 5. Mol Oncol. 2017. PMID: 28556483 Free PMC article.

9

Prognostic Significance of β-Catenin, E-Cadherin, and SOX9 in Colorectal Cancer: Results from a Large Population-Representative Series.

Bruun J, Kolberg M, Nesland JM, Svindland A, Nesbakken A, Lothe RA. Bruun J, et al. Among authors: kolberg m. Front Oncol. 2014 May 21;4:118. doi: 10.3389/fonc.2014.00118. eCollection 2014. Front Oncol. 2014. PMID: 24904831 Free PMC article.

10

Prognostic, predictive, and pharmacogenomic assessments of CDX2 refine stratification of colorectal cancer.

Bruun J, Sveen A, Barros R, Eide PW, Eilertsen I, Kolberg M, Pellinen T, David L, Svindland A, Kallioniemi O, Guren MG, Nesbakken A, Almeida R, Lothe RA. Bruun J, et al. Among authors: kolberg m. Mol Oncol. 2018 Sep;12(9):1639-1655. doi: 10.1002/1878-0261.12347. Epub 2018 Aug 15. Mol Oncol. 2018. PMID: 29900672 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

49 results

Search Page